HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Tanaka Selected Research

Chronic Hepatitis C

7/2021Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
6/2018Daclatasvir and asunaprevir improves health-related quality of life in Japanese patients infected with hepatitis C virus.
1/2012Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy.
8/2009Urinary bile acid sulfate levels in patients with hepatitis C virus-related chronic liver diseases.
10/2007Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.
4/2006Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
6/2005Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Tanaka Research Topics

Disease

32Myocardial Infarction
06/2022 - 02/2003
29Type 2 Diabetes Mellitus (MODY)
06/2022 - 09/2004
29Neoplasms (Cancer)
04/2022 - 03/2003
29Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 05/2002
27Heart Failure
06/2022 - 04/2007
22Thrombosis (Thrombus)
10/2022 - 02/2003
20Acute Coronary Syndrome
06/2022 - 07/2003
20Infections
04/2022 - 08/2004
17Atherosclerotic Plaque (Atheroma)
02/2021 - 01/2006
17Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 09/2004
15Liver Diseases (Liver Disease)
05/2022 - 05/2002
14Atrial Fibrillation
12/2022 - 04/2016
14Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 09/2004
14Sclerosing Cholangitis
04/2022 - 06/2010
13Inflammation (Inflammations)
01/2022 - 01/2007
12ST Elevation Myocardial Infarction
11/2022 - 11/2010
12Fibrosis (Cirrhosis)
05/2022 - 10/2007
12Atherosclerosis
04/2022 - 09/2004
11Autoimmune Hepatitis
01/2022 - 04/2006
11Rupture
01/2022 - 05/2005
11Disease Progression
01/2021 - 09/2007
10Chronic Renal Insufficiency
11/2022 - 10/2016
9Hemorrhage
12/2022 - 01/2007
8Autoimmune Diseases (Autoimmune Disease)
01/2022 - 12/2002
8Dyslipidemias (Dyslipidemia)
07/2021 - 12/2014
8Hypertension (High Blood Pressure)
01/2021 - 01/2016
7Pathologic Constriction (Stenosis)
05/2022 - 10/2010
7Hyperuricemia
04/2022 - 06/2016
7Carotid Artery Diseases
04/2022 - 01/2016
7AIDS-Related Complex (ARC)
02/2022 - 06/2009
7Chronic Hepatitis C
07/2021 - 06/2005
7Diabetes Mellitus
01/2021 - 01/2011
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2020
6Unstable Angina
09/2021 - 01/2006
6Fever (Fevers)
09/2021 - 06/2002
6Hepatocellular Carcinoma (Hepatoma)
07/2021 - 09/2006
6Infarction (Infarctions)
12/2020 - 03/2009
6Stable Angina
11/2019 - 01/2006
5Cholangitis
04/2022 - 01/2007
5Hyperemia
11/2020 - 02/2014
5Body Weight (Weight, Body)
09/2018 - 04/2016
5Vesicular Stomatitis
01/2017 - 01/2005
5Neointima
03/2013 - 01/2004
4Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 09/2007
4Leukemia
05/2022 - 06/2002
4No-Reflow Phenomenon
02/2022 - 05/2002
4Neoplasm Metastasis (Metastasis)
01/2022 - 10/2018
4Death (Near-Death Experience)
09/2021 - 01/2017
4Obesity
07/2021 - 09/2004
4Carcinogenesis
01/2021 - 09/2006
4Heart Diseases (Heart Disease)
11/2020 - 10/2009

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
21LipidsIBA
02/2022 - 05/2002
17Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
14Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 01/2016
12EnzymesIBA
01/2022 - 04/2004
12Sodium-Glucose Transport ProteinsIBA
01/2021 - 01/2017
12AntibodiesIBA
01/2021 - 05/2002
11Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2021 - 06/2015
10Pharmaceutical PreparationsIBA
01/2022 - 11/2004
10AutoantibodiesIBA
01/2021 - 04/2004
10CytokinesIBA
01/2019 - 12/2002
9Immunoglobulin G (IgG)IBA
10/2021 - 04/2004
9Antiviral Agents (Antivirals)IBA
07/2021 - 10/2007
9C-Reactive ProteinIBA
12/2017 - 06/2002
8AutoantigensIBA
12/2020 - 05/2002
7Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2017
7Uric Acid (Urate)IBA
01/2022 - 06/2016
7Immunoglobulins (Immunoglobulin)IBA
10/2021 - 01/2015
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2021 - 02/2009
7empagliflozinIBA
01/2021 - 04/2016
6AlbuminsIBA
01/2022 - 12/2015
6Messenger RNA (mRNA)IBA
01/2022 - 06/2008
6Phenobarbital (Luminal)FDA Link
01/2022 - 10/2010
5AntigensIBA
06/2022 - 07/2002
5FebuxostatFDA Link
04/2022 - 06/2016
5CholesterolIBA
02/2022 - 01/2008
5RNA (Ribonucleic Acid)IBA
01/2022 - 06/2005
5CanagliflozinIBA
01/2021 - 04/2016
5Prednisolone (Predate)FDA LinkGeneric
01/2021 - 05/2006
5Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 01/2016
5Sitagliptin Phosphate (Januvia)FDA Link
11/2019 - 01/2016
5MetalsIBA
05/2015 - 07/2010
4AnticoagulantsIBA
12/2022 - 11/2020
4gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
07/2022 - 09/2003
4SodiumIBA
06/2022 - 01/2018
4BilirubinIBA
05/2022 - 01/2008
4Serum AlbuminIBA
12/2021 - 01/2018
4LDL CholesterolIBA
09/2021 - 07/2015
4GadoliniumIBA
06/2021 - 11/2010
4BezafibrateIBA
01/2021 - 06/2015
4Transaminases (Aminotransferases)IBA
01/2020 - 12/2014

Therapy/Procedure

42Therapeutics
12/2022 - 03/2004
29Percutaneous Coronary Intervention
11/2022 - 02/2003
20Stents
10/2022 - 11/2003
11Catheter Ablation
11/2020 - 04/2016
10Liver Transplantation
01/2022 - 12/2016
8Drug Therapy (Chemotherapy)
02/2022 - 06/2002
5Glycemic Control
01/2021 - 01/2016
4Vitrectomy
04/2020 - 02/2015